Sort
48,018 grants matching “immunotherapy”
T Cell Costimulatory Pathways: Functions and Interactions
$2,282,140Arlene H Sharpe · Harvard Medical School · P01 · FY2018 · AI
The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
$2,281,895Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
City of Hope Lymphoma SPORE
$2,281,754City Of Hope/Beckman Research Institute · P50 · FY2005 · CA
Vaccine Induced Immunity in the Young and Aged
$2,281,308Rafi Ahmed · Emory University · U19 · FY2020 · AI
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
$2,281,096Song Yao · Roswell Park Cancer Institute Corp · UH3 · FY2024 · CA
DNA Sequencing and FACS Core Facilities
$2,280,383Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,278,344Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
SPORE in Prostate Cancer
$2,277,704Donald J. Tindall · Mayo Clinic Rochester · P50 · FY2007 · CA
COG NCTN Year 12 BIQSFP Progress Report
$2,276,944Douglas S. Hawkins · Public Health Institute · U10 · FY2025 · CA
Center for Cancer Biology Research
$2,276,007W Keith Miskimins · Sanford Research/Usd · P20 · FY2012 · GM
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$2,275,719Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Transcription factor regulation of CD4 and CD8 T cell effector and memory differentiation and function
$2,275,627Matthew Eugene Pipkin · University Of Florida · P01 · FY2022 · AI
Radiation and checkpoint blockade for cancer immune therapy
$2,275,599Robert H Vonderheide · University Of Pennsylvania · P01 · FY2021 · CA
Lymphoma Specialized Program of Research Excellence
$2,274,964University Of Iowa · P50 · FY2004 · CA
Lymphoma Specialized Program of Research Excellence
$2,274,631University Of Iowa · P50 · FY2005 · CA
SPORE in Gastrointestinal Cancers
$2,273,000Alison P Klein · Johns Hopkins University · P50 · FY2021 · CA
Mayo Clinic Breast Cancer SPORE
$2,272,470Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2019 · CA
Preclinical drug development in pancreatic cancer
$2,272,436Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
DNA Sequencing and FACS Core Facilities
$2,272,032Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Immunotherapy of low grade lymphoid malignancies
$2,271,399Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
UNDERSTANDING NEXT-GENERATION IMMUNOTHERAPY RESPONSES IN METASTATIC UVEAL MELANOMA
$2,271,024The Regents Of The University Of Colorado · · FY2024 · Defense Health Agency
Manufacturing of Drug Product, Dual Aβ/tau Vaccine for Clinical Trials
$2,270,000Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2023 · AG
Epigenetic Therapies - New Approaches
$2,269,729Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2021 · CA
Bone Marrow Transplantation in Human Disease
$2,269,507Richard J Jones · Johns Hopkins University · P01 · FY2019 · CA
ETIB Clinical Research Core
$2,268,710Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2013 · CA